Aliri has been a pioneer in spatial bioanalysis and spatial biology for over 15 years, harnessing innovative technologies and developing proprietary software and methods. Our expert team developed and patented quantification by MSI, making Aliri Bioanalysis the worldwide leader in spatial services.
We have performed 550+ drug development studies using Quantitative Mass Spectrometry Imaging and Multiplex Immuno-staining in various drug discovery stages in pharmacokinetics, translational research, and clinical stages. We also employ QMSI in metabolomics and lipidomics studies, providing direct insights into the tissue microenvironment, and our laboratory in Lille, France boasts a unique platform based on MALDI-FTICR instruments, offering the highest specificity and sensitivity for drug studies.
